Enterococcus faecium produces membrane vesicles containing virulence factors and antimicrobial resistance related

T Wagner1, B Joshi1, J Janice2

  • 1Research Group of Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Norway.

Insights

This study reveals that Enterococcus faecium releases membrane vesicles (MVs) carrying virulence factors and antimicrobial resistance proteins. These MVs may contribute to E. faecium pathogenicity and treatment challenges.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Molecular Biology

Background:

  • Enterococcus faecium is a significant nosocomial pathogen causing infections like bacteremia and endocarditis.
  • E. faecium exhibits inherent antimicrobial resistance and readily acquires new resistance traits, complicating treatment.
  • Bacterial membrane vesicles (MVs) are emerging as key mediators of intercellular communication and virulence factor dissemination.

Purpose of the Study:

  • To investigate the production and cargo of membrane vesicles (MVs) from clinically relevant Enterococcus faecium strains.
  • To characterize the proteomic content of E. faecium MVs, focusing on virulence factors and antimicrobial resistance determinants.
  • To explore the potential role of MVs in E. faecium pathogenicity and antimicrobial resistance.

Main Methods:

  • Isolation and morphological analysis of MVs from four distinct E. faecium strains.
  • Proteomic analysis to identify proteins associated with the isolated MVs.
  • Comparative analysis of MV protein content under different growth conditions.

Main Results:

  • Enterococcus faecium strains were confirmed to produce MVs.
  • Proteomic analysis identified numerous MV-associated proteins, including 11 virulence factors and 11 antimicrobial resistance proteins.
  • Notably, all proteins from the vanA-cluster of a vancomycin-resistant strain were found in its MVs.
  • MV-associated virulence factors included biofilm-promoting and extracellular matrix-binding proteins.

Conclusions:

  • E. faecium MVs play a significant role in disseminating virulence factors and antimicrobial resistance genes.
  • These MVs contribute to E. faecium's colonization, pathogenicity, and resistance to antibiotics.
  • Understanding MV function is crucial for developing novel therapeutic strategies against E. faecium infections.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.5K
Introduction to Membrane Proteins01:16

Introduction to Membrane Proteins

The cell membrane, or plasma membrane, is an ever-changing landscape. It is described as a fluid mosaic where various macromolecules are embedded in the phospholipid bilayer. Among the macromolecules are proteins. The protein content varies across cell types. For example, mitochondrial inner membranes contain ~76% protein content, while myelin contains ~18% protein content. Individual cells contain many types of membrane proteins—red blood cells contain over 50—and different cell...
81.4K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
575
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.0K
Membrane Proteins01:30

Membrane Proteins

Plasma membranes have integral transmembrane proteins involved in facilitated transport. These proteins are collectively referred to as transport proteins, and they function as either channels for the material or as carriers themselves. Channel proteins have hydrophilic domains exposed to the intracellular and extracellular fluids and a hydrophilic channel through their core that provides a hydrated opening for solutes to pass through the membrane layers. Passage through the channel allows...
30.5K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
488